₩118300.00
₩0.00 (0.00%)
End-of-day quote: 05/17/2024
KOSE:A006280
GC Biopharma Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
₩1.63T | ₩1.71T | ₩1.54T | ₩1.50T | ₩1.36T | ₩1.33T | ₩1.29T | ₩1.20T | ₩1.05T | ₩975.33B | ₩888.17B | ₩811.77B | ₩767.91B | ₩793.05B | |
| GM % | Gross Margin % |
|
29.71% | 33.89% | 33.76% | 29.21% | 27.34% | 25.82% | 28.39% | 29.30% | 32.25% | 31.72% | 30.82% | 31.11% | 33.58% | 40.49% | |
| OM | Operating Margin |
|
2.08% | 4.72% | 4.79% | 3.34% | 3.07% | 3.76% | 7.01% | 6.55% | 8.75% | 9.92% | 8.87% | 9.15% | 11.12% | 19.69% | |
| EPS | Earnings Per Share |
|
₩0.00 | ₩-2333.00 | ₩5.74k | ₩10.80k | ₩7.10k | ₩-319.00 | ₩3.02k | ₩4.67k | ₩5.45k | ₩8.21k | ₩7.26k | ₩4.08k | ₩5.05k | ₩5.28k | ₩10.68k |
| Div. | Dividends |
|
₩1.75k | ₩2.00k | ₩2.00k | ₩1.50k | ₩1000.00 | ₩1000.00 | ₩1.25k | ₩1.25k | ₩1.75k | ₩1.25k | ₩1.25k | ₩1.19k | ₩1.43k | ₩0.00 | |
| PR % | Payout Ratio % |
|
-75.01% | 34.87% | 18.53% | 21.14% | -313.48% | 33.15% | 26.80% | 22.93% | 21.31% | 17.22% | 30.62% | 23.56% | 27.05% | 0 | |
| Sha. | Shares |
|
11.41m | 11.41m | 11.41m | 11.41m | 11.41m | 11.41m | 11.41m | 11.41m | 11.56m | 11.56m | 11.56m | 10.62m | 10.62m | 10.27m | |
| OCF | Operating Cash Flow |
|
₩-5472.81M | ₩119.15B | ₩125.98B | ₩35.97B | ₩40.29B | ₩14.41B | ₩57.88B | ₩-1742.29M | ₩45.24B | ₩56.76B | ₩29.69B | ₩50.76B | ₩54.86B | ₩84.97B | |
| FCF | Free Cash Flow |
|
₩-33.33M | ₩61.16B | ₩23.66B | ₩-46902.04M | ₩-87163.08M | ₩-26976.32M | ₩28.39B | ₩-35870.84M | ₩-41656.86M | ₩20.81B | ₩-54035.50M | ₩-14463.70M | ₩11.33B | ₩56.30B | |
| FCFS | Free Cash Flow Per Share |
|
₩-11431.86 | ₩4.61k | ₩220.33 | ₩-5716.82 | ₩-9307.38 | ₩-4403.45 | ₩893.73 | ₩-8678.89 | ₩-7814.75 | ₩-1206.34 | ₩-5340.33 | ₩-2244.19 | ₩-13.26 | ₩5.71k |
